• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bicara Therapeutics Inc. - Common Stock (NQ:BCAX)

16.25 -0.21 (-1.28%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 538,592
Open 16.41
Bid (Size) 16.24 (16)
Ask (Size) 16.25 (4)
Prev. Close 16.46
Today's Range 15.93 - 16.91
52wk Range 7.800 - 28.09
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology
October 27, 2025
Via Investor Brand Network
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology
October 27, 2025
EQNX::TICKER_START (OTCQB:OTLC),(NASDAQ:IOBT),(NYSE:NVS),(NASDAQ:BCAX),(NYSE:PFE) EQNX::TICKER_END 
Via FinancialNewsMedia

Performance

YTD
-4.0%
-4.0%
1 Month
-2.8%
-2.8%
3 Month
+46.1%
+46.1%
6 Month
+16.1%
+16.1%
1 Year
-32.3%
-32.3%

More News

Read More
These stocks that are showing activity before the opening bell on Monday.
October 13, 2025
Via Chartmill
Bicara Therapeutics Announces Ficerafusp Alfa Granted Breakthrough Therapy Designation by U.S. FDA for 1L HPV-Negative R/M HNSCC
October 13, 2025
From Bicara Therapeutics Inc.
Via GlobeNewswire
4 Biotech Stocks Seeing Explosive Momentum Gains
October 07, 2025
Via Benzinga
Topics ETFs Stocks
Bicara Therapeutics to Participate in Upcoming Investor Conferences
August 27, 2025
From Bicara Therapeutics Inc.
Via GlobeNewswire
Bicara Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
August 12, 2025
From Bicara Therapeutics Inc.
Via GlobeNewswire
Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors
June 11, 2025
From Relay Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
June 04, 2025
Via Benzinga
Bicara Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
June 03, 2025
From Bicara Therapeutics Inc.
Via GlobeNewswire
Bicara Therapeutics Demonstrates Deep and Durable Responses with Ficerafusp Alfa Plus Pembrolizumab in 1L HPV-Negative R/M HNSCC at ASCO 2025
June 01, 2025
From Bicara Therapeutics Inc.
Via GlobeNewswire
Bicara Therapeutics Shares Sink Over 43% On Mixed Phase 1/1b Trial Results: What's Going On?
May 23, 2025
Via Benzinga
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
May 23, 2025
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
May 23, 2025
Via Benzinga
Let's take a look at the stocks that are in motion in today's session.
May 23, 2025
Via Chartmill
Gold Gains Over 1%; Ross Stores Shares Dip After Pulling Fiscal 2026 Outlook
May 23, 2025
Via Benzinga
There are notable gap-ups and gap-downs in today's session.
May 23, 2025
Via Chartmill
Nasdaq Down Over 1%; Workday Shares Tumble After Q1 Results
May 23, 2025
Via Benzinga
Merus Skyrockets On 'Unprecedented' Cancer Results, Slamming Bicara Therapeutics
May 23, 2025
Via Investor's Business Daily
Ross Stores, Deckers Outdoor, Xerox Holdings And Other Big Stocks Moving Lower In Friday's Pre-Market Session
May 23, 2025
Via Benzinga
Discover the top movers in Friday's pre-market session.
May 23, 2025
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 23, 2025
Via Benzinga
Pentair To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Friday
May 16, 2025
Via Benzinga
Bicara Therapeutics Announces Publication of an Abstract with Updated Interim Data from Phase 1/1b Trial of Ficerafusp alfa in 1L R/M HNSCC at the 2025 ASCO Annual Meeting
May 22, 2025
From Bicara Therapeutics Inc.
Via GlobeNewswire
Bicara Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
May 13, 2025
From Bicara Therapeutics Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Bicara Therapeutics Inc. - Common Stock publicly traded?
Yes, Bicara Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Bicara Therapeutics Inc. - Common Stock trade on?
Bicara Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Bicara Therapeutics Inc. - Common Stock?
The ticker symbol for Bicara Therapeutics Inc. - Common Stock is BCAX on the Nasdaq Stock Market
What is the current price of Bicara Therapeutics Inc. - Common Stock?
The current price of Bicara Therapeutics Inc. - Common Stock is 16.25
When was Bicara Therapeutics Inc. - Common Stock last traded?
The last trade of Bicara Therapeutics Inc. - Common Stock was at 10/31/25 04:00 PM ET
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap